Biomind Labs Inc.
BMNDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23 | $7 | $27 | $77 |
| - Cash | $0 | $0 | $0 | $2 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $24 | $8 | $27 | $75 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$3 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.016 | -0.04 | -0.06 |
| % Growth | 79% | 59.4% | 33.5% | – |
| Operating Cash Flow | -$0 | -$1 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$2 | -$2 |